Real-time enrollment status for this clonal mast cell disease clinical trial
Current Status
Recruiting
Checked: October 21, 2026 at 10:08 PM UTC
| NCT Number | NCT07143669 |
| Recruiting Status | Recruiting |
| Condition | Clonal Mast Cell Disease |
| Phase | Clinical Trial |
| Target Enrollment | 750 participants |
| Active Locations | 25 sites in the US |
| Sponsor | Blueprint Medicines Corporation |
| Last Updated on CT.gov | October 7, 2026 (2 weeks ago) |
As of October 21, 2026: Clinical trial NCT07143669 is currently recruiting participants. This clinical trial study for clonal mast cell disease is actively seeking new participants at 25 locations across the United States. The study is sponsored by Blueprint Medicines Corporation. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07143669 is actively recruiting participants as of October 21, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 25 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07143669 was last updated 2 weeks ago (October 7, 2026). HelloStudys verifies this status automatically.